MaNGO is the acronym for Mario Negri Gynecologic Oncology group.

Since the early 1990s, the Mario Negri Institute has been actively working on national and international onco-gynecological clinical studies, often in close collaboration with the English Medical Research Council Clinical Trial Unit. In particular, the international ICON 1, 2, 3 and 4 studies, conducted between 1991 and 2002 with the participation of almost 5000 patients, 47% of whom were recruited by the Italian collaborative network.

Thanks to the encouragement of Professor Costantino Mangioni, true precursor of clinical research in oncological gynecology, the MaNGO group was formally established in May 2006 with the aim of maintaining this scientific tradition and improving the visibility of the Italian contribution.

MaNGO was born also to interact with the main international networks currently coordinating the collaboration between clinical research groups: the Gynecologic Cancer Intergroup (GCIG) and the European Network for Gynaecological Oncological Trial groups (ENGOT). Participation in these international forums allows access to the most qualified clinical research proposals and subgroups of work with specific areas of interest.

The network of MaNGO centers is made up of public, private and university hospitals and includes distinguished and eminent oncoginecological Scientists.